Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aronow

Showing results (61-70 of 1,699) with videos related to

Pageof 170
Sort By:
Chest|July 1, 1978
Effect of ambient level of carbon monoxide on cardiopulmonary diseaseW S Aronow
JAMA|September 23, 1974
Tobacco and the heartW S Aronow
Geriatrics|October 5, 2001
Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CADW S Aronow
Lancet (London, England)|October 5, 2001
Approach to symptomatic coronary disease in the elderly: TIME to change?W S Aronow
Journal of the American Geriatrics Society|June 12, 1999
Management of the older person with atrial fibrillationW S Aronow
Drug Safety|September 12, 2002
Myocardial infarction in the elderly: benefits and risks of thrombolyticsWilbert S Aronow
Lancet (London, England)|September 21, 2002
Clinical judgmentWilbert S Aronow
The American Journal of Geriatric Cardiology|June 21, 2001
Treatment of Hypertension in the Institutionalized ElderlyWilbert S. Aronow
Journal of the American Geriatrics Society|April 13, 2001
Effect of beta blockers on mortality and morbidity in persons treated for congestive heart failureW S Aronow
Journal of the American Geriatrics Society|May 20, 2003
Effect of statins on mortality and cardiovascular events in elderly high-risk personsWilbert S Aronow
Pageof 170

Showing results (61-70 of 1,699) with videos related to

Sort By:
Pageof 170
Chest|July 1, 1978
Effect of ambient level of carbon monoxide on cardiopulmonary diseaseW S Aronow
JAMA|September 23, 1974
Tobacco and the heartW S Aronow
Geriatrics|October 5, 2001
Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CADW S Aronow
Lancet (London, England)|October 5, 2001
Approach to symptomatic coronary disease in the elderly: TIME to change?W S Aronow
Journal of the American Geriatrics Society|June 12, 1999
Management of the older person with atrial fibrillationW S Aronow
Drug Safety|September 12, 2002
Myocardial infarction in the elderly: benefits and risks of thrombolyticsWilbert S Aronow
Lancet (London, England)|September 21, 2002
Clinical judgmentWilbert S Aronow
The American Journal of Geriatric Cardiology|June 21, 2001
Treatment of Hypertension in the Institutionalized ElderlyWilbert S. Aronow
Journal of the American Geriatrics Society|April 13, 2001
Effect of beta blockers on mortality and morbidity in persons treated for congestive heart failureW S Aronow
Journal of the American Geriatrics Society|May 20, 2003
Effect of statins on mortality and cardiovascular events in elderly high-risk personsWilbert S Aronow
Pageof 170